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Abstract
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Indications exist that paramagnetic calcium phosphates may be able to promote regeneration of
bone faster than their regular, diamagnetic counterparts. In this study, analyzed was the influence
of paramagnetic cobalt-substituted hydroxyapatite nanoparticles on osteoporotic alveolar bone
regeneration in rats. Simultaneously, biocompatibility of the material was tested in vitro, on
osteoblastic MC3T3-E1 and epithelial Caco-2 cells in culture. The material was shown to be
biocompatible and nontoxic when added to epithelial monolayers in vitro, while it caused a
substantial decrease in the cell viability as well as deformation of the cytoskeleton and cell
morphology when incubated with the osteoblastic cells. In the course of six months after the
implantation of the material containing different amounts of cobalt, ranging from 5 – 12 wt%, in
the osteoporotic alveolar bone of the lower jaw, the following parameters were investigated:
histopathological parameters, alkaline phosphatase and alveolar bone density. The best result in
terms of osteoporotic bone tissue regeneration was observed for hydroxyapatite nanoparticles with
the largest content of cobalt ions. The histological analysis showed a high level of reparatory
ability of the nanoparticulate material implanted in the bone defect, paralleled by a corresponding
increase in the alveolar bone density. The combined effect of growth factors from autologous
plasma admixed to cobalt-substituted hydroxyapatite was furthermore shown to have a crucial
effect on the augmented osteoporotic bone regeneration upon the implantation of the biomaterial
investigated in this study.
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Introduction
Osteoporosis is a metabolic disease that affects millions of people around the globe. It is a
progressive, systemic skeletal disease characterized by low bone density and microarchitectural bone damage, with the consecutive increase in bone fragility and susceptibility
to fracture [1]. Osteoporosis of cancellous bone leads to thinning of trabeculae, widening of
marrow and decreased bone density in the center of the bone, while in the cortical region
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overall thinning occurs at the periphery [1–3]. One of the approaches for treating
osteoporosis in oral and maxillofacial areas has involved implantation of different types of
biomaterials [3–7]. The quest for materials performing better than those currently in use is,
however, ongoing, with a special focus on nanoparticulate biomaterials.
A special attention in implantology and prosthetics is nowadays directed towards synthetic
materials with the properties of natural bone, such as biomaterials composed of
hydroxyapatite (HAp) [8, 9]. HAp is chemically similar to mineral components of bone and
hard tissues in mammals, and is also bioconductive, that is, it supports bone growth and
osseointegration. Reconstructions of mandibular bone defects using HAp have been in
clinical practice for more than 20 years now [10]. Fillers based on HAp have also been used
for the reconstruction of osteoporotic bone defects prior to fixation [11]. HAp in
combination with bisphosphonates has also showed satisfactory results in the treatment and
reconstruction of osteoporotic bone [12]. In addition, nanoparticulate HAp may have
advantages over its microparticulate forms in terms of enabling greater osseointegration
enhancement [13]. Osteoblast adhesion was thus shown to be stronger on compacts
composed of nanoparticulate HAp than on those comprising microsized particles of the
same chemical composition [14].
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Physicochemical and biological properties of HAp can be amplified via modification of its
composition and crystal structure [15]. Various elements have been used to dope HAp with
in order to modify its properties [16, 17, 18]. Strontium-substituted HAp was synthesized as
a potential material for the reconstruction of osteoporotic bone [19]. Reported were also in
vitro studies on HAp systems combined with maghemite, showing significantly enhanced
proliferation and differentiation of osteoblasts under static magnetic fields [20]. These
results indicate that the magnetic field may be an important factor applicable in augmenting
bone tissue regeneration and increasing the efficacy of the treatment of bone defects in bone
tissue engineering [21].
Cobalt as a substitute in HAp was chosen because: (a) it has not been assessed yet as an
ionic substitute for calcium in HAp applicable in reparation of hard tissues; (b) it has
previously been shown as able to provide a finite magnetic moment in magnetic field to
otherwise diamagnetic pure HAp, with saturation magnetizations reaching 10 emu/g at 5 K;
and (c) it has been used as an element of alloys applied as surgical implants for years [22].
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The research reported here aimed to investigate the influence of nanoparticulate HAp in
whose crystal lattice Ca2+ ions were partially substituted with different amounts of Co2+
ions on the time scale required for the development of angiogenesis and regeneration of
osteoporotic alveolar bone in vivo. Co2+ ions from the implanted Ca/Co-HAp nanomaterial
were hypothesized to be able to act in synergy with aminopeptidase enzymes and boost
proliferation and migration of the endothelial cells important for the process of osteogenesis.
Each bone substitute that enhances osteogenesis may be useful in strengthening the
weakened osteoporotic bone. Co-substituted HAp was examined in this study for its ability
to act as one such osteogenic implant in reparation of osteoporotic jawbone. In order to
improve angiogenesis, the effect of blood and blood plasma as catalyst components,
admixed to Ca/Co-HAp, was investigated as well. Simultaneously, tests were conducted to
assess biocompatibility of the given particles in vitro, and that on osteoblastic MC3T3-E1
and epithelial Caco-2 cells in culture.

Materials and methods
Powders of calcium hydroxyapatite (HAp) and calcium cobalt hydroxyapatite (Ca/Co-HAp),
in which Ca ions are replaced with ~ 5% (HAp/Co1) and ~ 12% (HAp/Co2) of Co2+ ions,
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were synthesized hydrothermally in a stainless steel reactor (Parr 4530 Floor Stand Pressure
Reactor) at a temperature of 200 °C and constant mixing of 400 rpm during 8 h [23, 16]. The
phase composition of the synthesized material was determined by means of X-ray
diffraction (XRD; Philips PW1050 diffractometer with Cu Kα1,2 Ni – filtered radiation).
The size distribution of the particles was determined after intense sonication of dry and
suspended powders by means of laser diffraction (LD) particle size analysis (Malvern
Instruments Mastersizer 2000). Morphological characteristics were measured using field
emission scanning electron microscopy (Carl Zeis FE SEM Suppra 35VP). Co content was
confirmed using inductively coupled plasma (ICP) emission spectroscopy analysis (Thermo
Scientific iCAP 6300 spectrometer) [16].

In vitro experimental design
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Mouse calvarial preosteoblastic cell line, MC3T3-E1 subclone 4, and the human intestinal
Caco-2 cell line were both purchased from American Tissue Culture Collection (ATCC,
Rockville, MD). MC3T3-E1 cells were cultured in Alpha Minimum Essential Medium (αMEM; Gibco) supplemented with 10% fetal bovine serum (FBS, Invitrogen) and no ascorbic
acid (AA). Caco-2 cells were cultured in Eagle’s Minimum Essential Medium with Earle’s
Balanced Salt Solution, 1 mM sodium pyruvate, 20% fetal bovine serum (Sigma), and 1%
penicillin-streptomycin antibiotic solution. The medium was replaced every 48 h, and the
cultures were incubated at 37 °C in a humidified atmosphere containing 5% CO2. Every 7
days, the cells were detached from the surface of the 75 cm2 cell culture flask (Greiner BioOne) using 0.25 wt% trypsin, washed, centrifuged (1000 rpm × 3 min), resuspended in 10
ml of the cell culture medium and subcultured in 1:7 volume ratio. Cell passages 6 – 12
were used for the experiments reported hereby. The cultures were regularly examined under
an optical microscope to monitor growth and possible contamination.
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MC3T3-E1 cells were seeded on glass cover slips placed in 24 well plates and 500 μl of αMEM supplemented with 10% fetal bovine serum (FBS, Invitrogen) and no AA at the
density of 6 × 104 cells per well. After 5 days of incubation, nearly confluent cells were
treated with α-MEM containing 50 μg/ml AA as the mineralization inductor. At the same
time, 2 mg/cm2 of particles were added to the cells and incubated for 7 days. Alpha-MEM
supplemented with 50 μg/ml AA was replenished every 48 h. After the given period, one
portion of cells was fixed for 15 min in 3.7 wt% paraformaldehyde at room temperature and
then stained for f-actin and nucleus using phalloidin-tetramethylrhodamine (AlexaFluor 555,
Invitrogen) and 4′,6-diamidino-2-phenylindole dihydrochloride nuclear counterstain (DAPI,
Invitrogen), following a previously described protocol [24]. The cover slips containing the
fixed and stained cells were mounted onto glass slides using hard set vectashield and nail
hardener and were subsequently imaged on a confocal laser scanning microscope – C1si
(UCSF Nikon Imaging Center) at 60 – 100 x magnification in oil. All the experiments were
carried out in triplicates. The other portion of the cells was used for running an MTT (3-[4,
5-dimethylthiazol-2-yl]-2, 5-diphenyl tetrazolium bromide) in vitro toxicological assay. The
test proceeded by adding 20 μl of 5 mg/ml MTT (Sigma M-5655) in PBS to each well
already containing 200 μl of cell culture media. Following 2 h incubation at 37 °C, 220 μl of
MTT solubilization solution (Sigma M-5655) were added to each well. The plate was
shaken at room temperature for an hour and samples from each well were analyzed for
absorbance at 570 nm on a UV/Vis spectrophotometric microplate reader (Molecular
Devices: Spectra Max 190). All the particle types were analyzed in triplicates and the
resulting absorbance values were normalized to the negative control.
Caco-2 cells were seeded at the density of 7.5 × 104 cells/well in 24 well plates and reached
confluency in 5 – 7 days. To ensure that the cells were polarized at the onset of the
experiment, the latter began only when the cells seeded in parallel in Transwells placed in
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24 well plates at the same density of 7.5 × 104 cells/well reached trans-epithelial electrical
resistance (TEER) values of > 1000 Ω. Confluent, polarized Caco-2 cells grown on glass
slides in 24 well plates were treated with 2 mg/cm2 of particles resuspended in 500 μl of the
cell culture medium, and incubated for 4 h at 37 °C. After the given incubation period, the
epithelial cells were fixed for 5 min in −20 °C methanol and then stained for zonula
occludens-1 (ZO-1) and nucleus using rabbit anti-ZO-1 primary antibody (Zymed Lab),
AlexaFluor 555 goat anti-rabbit IgG secondary antibody (Invitrogen), and 4′,6-diamidino-2phenylindole dihydrochloride nuclear counterstain (DAPI, Invitrogen), respectively,
following a previously described [24]. Cover slips containing the fixed and stained cells
were mounted onto glass slides using vectashield and nail hardener and imaged in oil under
a confocal laser scanning microscope – C1si (UCSF Nikon Imaging Center) at 60 – 100 x
magnification. All the experiments were done in triplicates. Volume-rendered z-stack
images (12 – 15 of them) spaced by 1 μm were collected at identical laser intensities and
analyzed for the fluorescence intensity using ImageJ and NIS Elements software. The
thickness of ZO-1 conglomerates at the tight junction was measured as half-width of peaks
obtained by plotting the fluorescence intensity profiles across the cell boundary.

In vivo experimental design
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The study was conducted on female Wistar rats. The animals were introduced into the
experiment when they were 6–8 weeks old, which is the period of their full sexual maturity
and mineralization of bone tissue. During the experiment, the animals were fed and watered
ad libitum and were exposed to light and darkness regimen in duration of 12 hours for each
period. Animals were divided into two groups, so that one group of 8 animals was the
control (K), and a second one was experimental (E). The latter group consisted of 40
animals, all of which were treated with glucocorticoids in order to induce osteoporosis. The
animals were given two types of glucocorticoids: methylprednisolone Na-succinate (Lemod
Solu, Hemofarm Vršac, Serbia) at 2 mg per kg of body weight, and dexamethasone-Naphosphate (Dexason, ICN Galenika, Belgrade, Serbia) at 0.2 mg per kg of body weight.
These osteoporosis-inducing agents were administered intramuscularly and alternating for
12 weeks, so that every day the animals were given a different glucocorticoid. A model of
osteoporosis of rat mandible wherein osteoporosis was formed after such treatment was
presented in our previous articles [25, 26]. Animals from the control group received daily
intramuscular saline solution during this specified 12-week period.
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At the end of 12 weeks, defects were created on the left side of the alveolar bone of
mandible, in the region between the midline and the mental foramen, in all the animals. The
defects were made using sterile steel borer with 1.6 mm in diameter and 1.8 mm in length,
which was smaller than the critical size because it was necessary to avoid the risk of fracture
that osteoporotic bone is susceptible to. The animals were prepared for this intervention with
an injection of diazepam (Bensendin, ICN Galenika, Belgrade, Serbia) and the subsequent
induction of anesthesia using ketamine hydrochloride USP (Ketalar, Rotexmedica Gmbh,
Trittau, Germany).
The animals from group E were divided into 5 subgroups (each consisting of 8 animals) for
implantation of the following nanostructured powders: HAp, HAp/Co1, and HAp/Co2.
HAp/Co2 powder was also applied after being admixed to autologous blood and autologous
blood plasma. All three samples were mixed prior to implantation with saline (0.9% NaCl
solution). The weight ratio of autologous blood or blood plasma and the admixed HAp/Co2
powder was 2:1. The plasma was prepared following a procedure described in the literature
[25]. The mandibular defects in rats from group K were not filled, but were left to heal
spontaneously, so as to provide a reference to compare the osteoporotic bone regeneration
aided by the implanted nanoparticles to. The animals in both groups (E and K) were
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sacrificed 6 and 24 weeks after the implantation since previous studies have shown that best
results can be expected during this period [26, 27]. The procedures involving experimental
animals were done in accordance with the Guidelines for Work with Experimental Animals
adopted by the Ethics Committee of the Faculty of Medicine, University of Niš, Serbia.
After 6 and 24 weeks of implantation, samples of the alveolar bone were decalcified,
dehydrated in a series of alcohol and embedded in paraffin blocks (n = 5 for each animal).
Of these blocks were made 10-μm-thin slides, which were then stained by H&E and
Masson’s Trichrome Kit for histopathological analysis, with the minimum of three slides per
staining [25, 28]. The microscopic analysis of the defect area and its immediate
surroundings in the healthy and osteoporotic bone was performed. After the specified time
(6 and 24 weeks) blood samples were taken for a biochemical analysis and alkaline
phosphatase (ALP) activity was determined on an Olympus AU 680 analyzer according to a
standard method presented in the literature [29]. After the same treatment times a change in
the local bone mineral density (BMD) of jaw was measured using the dental scanner for
computerized tomography [30, 31]. The density was determined at the site of the defect with
a depth of 1.8 mm and on the surface area of 3 mm2, which included both the area of the
defect and its bone boundary. The control was a healthy bone of untreated rats determined
under the same conditions. BMD measurements in Hounsfield units were carried out using
the scanning protocol described by Homolka et al. [32], modified to fit the size of the object.
The results were statistically analyzed by MANOVA test.

NIH-PA Author Manuscript

Results and discussion
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Fig. 1a shows XRD patterns of the materials used in this study (HAp, HAp/Co1, and HAp/
Co2), demonstrating that all of them consisted of pure, monophasic apatite. Ritvield
crystallographic analysis and Raman spectroscopy confirmed replacement of Ca2+ ions with
Co2+ ions in the crystal lattice of HAp during the hydrothermal synthesis [23]. The partial
Ca2+-to-Co2+ substitution entailed a reduction in the unit cell volume, from 529 A3 for HAp
to 524 A3 for HAp/Co2, as well as a reduction in the average crystallite size, from 40 nm for
HAp to 26 nm for HAp/Co1 to 14 nm for HAp/Co2, as indicated by the broadening of the
diffraction lines in direct proportion with the content of Co2+ ions in HAp/Co [16]. The
particle size distribution profiles for different samples are shown in Fig. 1b. The median
diameters of primary particles were calculated to be 94, 63 and 71 nm for HAp, HAp/Co1
and HAp/Co2, respectively. The introduction of Co2+ ions to HAp lattice not only decreases
the crystallite size, lowers crystallinity and affects the particle morphology, but it also
promotes agglomeration in direct proportion with an increase in the content of Co2+ [16,
23]. Consequently, HAp/Co1 has the smallest mean particles size. SEM images of HAp and
HAp/Co1 samples are shown in Fig. 1c–d, demonstrating a considerable extent of
agglomeration in both samples as well as a difference in the particle size and morphology
brought about by incorporation of Co2+ ions into the crystal structure of HAp.
Fig. 2 demonstrates no significant damage done by HAp particles with the largest content of
Co (HAp/Co2) to the epithelial monolayers of Caco-2 cells under the given experimental
conditions, as evidenced by the preserved cobblestone pattern of ZO-1 molecules. ZO-1 is a
perijunctional protein that acts as a link between actin cytoskeletal microfilaments and the
transmembrane proteins of the tight junction [33]. Any toxic effects exhibited by the
particles would appear as either discontinued or extensively ruffled ZO-1 pattern. Although
ruffling of the ZO-1 pattern was observed following incubation with Co-substituted HAp
(Fig. 2b), the integrity of the tight junction was preserved. Certain drugs were also shown to
negatively affect epithelial monolayers by inducing focal aggregation of the tight junction
proteins, including ZO-1, and their colocalization with the disrupted cytoskeletal filaments
along the cell boundaries [34]. This effect was, however, not observed upon the application
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of Co-substituted HAp. No significant change with respect to the negative control was
observed either in the thickness of ZO-1 conglomerates at the tight junction.
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Incubation of HAp/Co particles however produced a somewhat unviable response by the
osteoblastic cells. As shown in Fig. 3b–c, f-actin microfilaments in some cells appeared
partially disrupted, lacking the striated appearance of the negative control (Fig. 3a).
Cytoskeleton of other cells appeared relatively healthy, although their density was markedly
diminished (Fig. 3d). A portion of cells, especially those in direct contact with the particles,
clearly displayed apoptotic morphologies (Fig. 3e). Despite that, the osteoblastic cells were
observed to be well spread (Fig. 3f), suggesting the dual effect of the particle surface:
osteoconductivity on one side and moderate toxicity on the other. Inhibited proliferation of
cells was detected in the presence of all HAp/Co particles, as apparent from the lower cell
density in comparison with the control sample. Mineralization centers were, however, still
observed within the cells, indicating their continued mineralization activity. Furthermore,
the results of the MTT assay shown in Fig. 4 demonstrate a decrease in the mitochondrial
activity of the cells, indicative of the cell viability, in direct proportion with the Co content
in HAp/Co particles, from 5 wt% (HAp/Co1) to 9 wt% to 12 wt% (HAp/Co2). Moderate
cytotoxicity of cobalt ions and nanoparticles has been demonstrated previously in various in
vitro studies [35], and Co2+ levels of around 400 μM were shown to correspond to IC50
values for apoptosis of C6 glioma cells [36]. Dose-dependent cytotoxicity, in agreement
with our findings, was also previously observed during dosage of Vero cells with cobalt
chloride [37]. A study aimed to evaluate the released amount of a range of divalent cationic
substitutes from HAp in cell culture media has come to conclusion that the second largest
released amount is that of Co2+, only surpassed by Cu2+ [38]. In the latter study, the amount
of macrophages identified positively for apoptosis reached 100 % when incubated with Cosubstituted HAp, while at the same time osteoblasts adhered to Co-substituted HAp better
than to any other divalent-cation-substituted HAp, a result consistent with our findings.
Whereas toxicity of cobalt ions has been regularly demonstrated on cell cultures, less
evident has been toxicity of cobalt to whole organisms [39] exposed to small to moderate
amounts thereof, although there are cases documented in the literature [40, 41, 42]. In any
case, while Co2+ ions released from HAp/Co particles in cell culture conditions are nowhere
as rapidly cleared as in the body, higher levels of toxicity are naturally expected in the
former case, and our in vivo findings, demonstrating favorable regeneration of osteoporotic
bone treated with the paramagnetic HAp/Co, are supportive of this observation.
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Fig. 5 shows the histopathology of alveolar bone 6 weeks after the implantation.
Histopathological slides of the sections of mandible from the control group (Fig. 5a) reveal
homogeneous areas without holes, representing compact bone, and an area with numerous
interconnected cavities, representing cancellous bone. The compact part of the alveolar bone
shows usual collagenesis and osteogenesis for the given healing interval. Overall, the control
samples exhibited normal bone texture, in both its compact and cancellous parts. In Fig. 5b,
one could see the ongoing destruction of the implanted nanomaterial and the formation of
young bone in the proximity of the defect wherein the biomaterial was implanted. In Fig. 5c,
one can spot an area of mandibular bone covered with a layer of periosteum and a layer of
connective tissue. Filling of the defect with the newly formed bone typified by intense
angiogenesis is seen along the edges. Replacement of the implanted nanomaterial with this
young bone, discernable by distinct cement lines and islets of fibrous tissue, can also be seen
from Fig. 5d. Large blood vessels (diameter>30 μm) were somewhat present in all the
specimens, whereas an abundance of capillaries was observed, especially when HAp/Co2
was applied. The blood vessels were seen 24 weeks after the implantation and their average
number in 8 × 106 μm2 surface section area was 1.78±1.39, 2.33±2.00, 2.67±1.00 and
3.33±1.22 for K, HAp, HAp/Co1, and HAp/Co2 samples, respectively. These results
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indicate an intense process of angiogenesis and filling of the defects with young bone 6
weeks after the implantation of HAp/Co2 material. Angiogenesis plays an important role in
the formation of bone tissue during the reparation of bone fractures and was more intense for
HAp/Co2 compared to other analyzed materials (HAp, HAp/Co1).
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Fig. 6 shows the histopathology of alveolar bone 24 weeks after the implantation. In the
control group (Fig. 6a), an even more intense formation of the new bone is seen as well as
rapid incorporation of Ca2+ into the existing bone matrix, indicating the ongoing
mineralization. Bone regenerated in the presence of Co-free HAp implants (Fig. 6b)
demonstrates resorption and replacement of the implanted material paralleled by
osteogenesis and bone regeneration. Continuation of defect ossification is observed for
HAp/Co samples too and for HAp/Co1 the bone defect appears to be completely filled with
the new bone (Fig. 6c). The presence of collagen, Haversian canals, cement lines as well as
the beginning of ossification and calcification can be observed. Angiogenesis, the thick
cement lines, a number of Haversian canals, a vast number of osteogenesis cells in the
process of calcification and obturations of the artificial defect were also seen in the
mandibular specimens regenerated in the presence of HAP/Co2 (Fig. 6d). These
observations suggest that vascularization is essential during osseointegration because it
directly affects the processes of differentiation and ossification of bone tissue. These
processes affect remodeling, adaptation and consolidation of the newly formed bone, which
can last for several months [41]. Osteogenesis observed after 24 weeks of implantation of
HAp/Co2 material (Fig. 6d) is very similar to that present in healthy bone tissue [43].
The content of ALP and alveolar bone density measured 6 and 24 weeks after the
reconstruction of osteoporotic bone has been initiated are given in Fig. 7. The highest
density of alveolar bone, although not statistically significant in comparison with the control
(K), was detected for bone regenerated by means of HAp/Co2, the material that was further
on mixed with blood and blood plasma to investigate its potential for improving regenerative
processes to a greater extent. The blood levels of ALP, a mineralization marker, were
markedly higher for all HAp materials, with and without Co, with respect to the control, as
in agreement with the greater degree of ossification observed in the given samples when
compared to the control.
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Fig. 8 shows the histopathology of alveolar bone 6 and 24 weeks after the reconstruction
with HAp/Co2 mixed with either blood or blood plasma. The sample regenerated by means
of HAP/Co2/blood (Fig. 8a) shows minimal residues of the implanted material 6 weeks after
the reconstruction as well as the ongoing replacement of the implanted material with the
connective tissue and the onset of ossification. After 24 weeks, the activity of osteogenic
cells, the presence of young bone and a portion of mature calcified bone in its vicinity could
be additionally seen (Fig. 8c). A decent blood supply and the presence of Haversian systems
with cement lines, numerous collagen fibers, along with a similarly accelerated replacement
of the implanted material by the newly formed bone can also be seen in the sample
regenerated by means of HAP/Co2/blood after 6 weeks (Fig. 8b). After 24 weeks,
observable are the areas of ossification utilizing giant cells, while newly formed bone is
present as well as a number of cement lines, Haversian canals with mature bone around
them and numerous foci of calcification (Fig. 8d).
ALP, a specific biomarker of osteogenesis, as well as bone densities show a significant
increase when HAp/Co2 materials is implanted together with saline solutions, blood and
blood plasma (Fig. 9). The highest values of both ALP and bone density were detected when
HAp/Co2 was mixed with blood plasma before its application, as in consistency with the
previously presented histopathological results. ALP values increased between 6 and 24
weeks after the reconstruction, which may be caused by an imbalance in bone metabolism
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and increased bone resorption, a process similar to premenopausal and early menopause
changes [44, 45]. These changes are also due to sufficient time existent for the growth
factors, present in autologous blood and plasma, to associate with the osteogenic activity of
nanoparticles [13]. This, in turn, leads to significant changes in bone regeneration via an
increased excretion of ALP from the osteoblasts, more active when the bone matrix is
deposited in the phase of bone reconstruction.
The obtained results demonstrate the ability of Co-substituted HAp to accelerate (a)
osteogenesis and regeneration of osteoporotic bone, and (b) replacement of the implanted
material with a newly formed bone. Mild inflammation is known to ensue every facile
resorption of a biomaterial used in tissue reparation and a larger inflammatory capacity of
HAp/Co particles compared to HAp ones could have been an osteogenesis-promoting factor
in this case. Moderate cytotoxicity of the material could also facilitate the transport of Ca2+
ions in the intracellular fluid, further stimulating the osteogenic activity of osteoblasts.
Cobalt-substituted HAp could also induce cytokine production, which might lead to
enhanced exchange across the cell membrane. In the endoplasmatic reticulum, this could
lead to changes in acid/base balance, which might enhance the activity of aminopeptidases
and lead to an increased proliferation and migration of endothelial cells, a factor of vital
importance for the process of osteogenesis.
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HAp/Co2 mixed with blood or autologous plasma, rich in growth factors, also induces
generation of a large number of osteoblasts, leading to faster regeneration of osteoporosisweakened bone. This process entails a more rapid incorporation of mineral ions into HAp
crystal lattice of the newly formed bone. As the result, the process of intense mineralization
can be clearly observed 24 weeks after the reconstruction. Osteogenesis and regeneration of
the reconstructed defect 24 weeks after the implantation of HAp/Co2 material mixed with
autologous plasma (Fig. 8b) is very pronounced and the newly formed bone appears to be
identical to healthy bone. It is likely that the mononuclear cells are stimulated by the growth
factors from autologous blood and plasma as well as by the presumed increased production
of cytokines induced by Co2+ ions, so that they transform into macrophages turned active
and of greater capacity for phagocytosis due to an increased concentration of lysosomal
enzymes. The given stimuli produce migration and proliferation of fibroblasts, stimulation
of collagen synthesis and activation and synthesis of metalloproteinases, enzymes that
participate in restructuring the extracellular matrix. These phenomena can be envisaged to
result in bone remodeling, adhesion, cell migration and multiplication of bone-forming cells,
including eventually full mineralization and mature bone formation at the site of the defect.
The synergetic effect of growth factors and thrombocytes from autologous plasma with
HAp/Co2 has thus led to an increased proliferation and migration of active cells that rapidly
obturate the artificial defect and improve the osteoporotic bone regeneration, as noted
previously [46].

Conclusion
The possibility of reconstruction of osteoporotic bone defects of the mandible using
hydroxyapatite and cobalt-substituted hydroxyapatite nanoparticles was investigated.
Biocompatibility tests carried out on cell cultures have shown intact monolayers of epithelial
cells in contact with cobalt-substituted hydroxyapatite and no negative effects on the cell
viability. In contrast, prolonged incubation of the given material with osteoblastic cells in
vitro resulted in partial morphological and cytoskeletal deformation of the cells as well as a
decrease in their viability in direct proportion with the content of cobalt ions incorporated in
the crystal lattice of hydroxyapatite. In contrast, an increase in the amount of calcium ions
substituted by cobalt, up to 12 wt%, corresponded to an increase in the rate of osteogenesis
and formation of the newly formed and mature calcified bone. After 24 weeks of
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reconstruction using nanosized cobalt-substituted hydroxyapatite with 12 wt% of cobalt
ions, an intense angiogenesis, vascularization, migration and multiplication of bone-forming
cells as well as maximal values of alkaline phosphatase and bone density have been
achieved. The combined effect of growth factors from autologous blood plasma and cobaltsubstituted hydroxyapatite had a crucial effect on the observed increase in cell proliferation
and migration of active cells that rapidly obturate the artificial defects, improve osteoporotic
bone regeneration and increase the bone density of the mandible.
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Fig. 1.

a) XRD patterns of synthesized materials; b) size distribution of particles obtained by LD; c)
and d) SEM images of nanopowder samples HAp and HAp/Co1, respectively.
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Fig. 2.

Immunofluorescent staining of ZO-1 molecules (a–b) and cell nucleus (c–d) in Caco-2 cell
monolayers treated with either no particles (control, a, c) or 2 mg/cm2 of HAp/Co2 particles
(b, d), imaged under identical excitations. The sizes of images (a, b) and (c, d) is 200 × 200
μm and 475 × 475 μm, respectively.
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Fig. 3.
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Confocal optical micrographs of fluorescently stained osteoblastic cell nucleus (blue) and
cytoskeletal f-actin (red), and HAp/Co particles and/or intracellular mineral particles (green)
following 7 days of incubation with either no particles (control, a) or 2 mg/cm2 of HAp/Co
particles (b–f). The size of each image is 750 × 750 μm.
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Fig. 4.
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Mitochondrial activity indicative of cell viability, normalized to the negative control (C−)
and determined by the MTT assay for HAp/Co particles containing different weight
percentage of Co2+ ions: 5 wt% (HAp/Co1), 9 wt% and 12 wt% (HAp/Co2).
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Fig. 5.

Histopathology of alveolar bone 6 weeks after the implantation: a) control group, b) HAp; c)
HAp/Co1 and d) HAp/Co2. [labels: 1 - compact bone, 2 - cancellous bone, 3 - replacement
of the material with new bone tissue, 4 - a young bone, 5 - cement lines, 6 - blood vessel, 7 the newly formed bone]
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Fig. 6.

Histopathology of alveolar bone 24 weeks: a) control group, b) HAp; c) HAp/Co1; d) HAp/
Co2. [labels: 5 - cement lines, 6 - blood vessel, 7 - the newly formed bone, 8 - Haversian
canals, 9 - bone mineralization, 10 - osteogenesis, 11 - the beginning of ossification and
calcification, 12 - collagen fibers, 13 - mature calcified bone]

NIH-PA Author Manuscript
J Mater Sci Mater Med. Author manuscript; available in PMC 2014 February 01.

Ignjatović et al.

Page 18

NIH-PA Author Manuscript

Fig. 7.

(a) ALP content (U/L) and (b) densities of alveolar bone expressed in Haunsfiled units
(HU), 6 and 24 weeks after the implantation, for different experimental groups (HAp, HAp/
Co1, HAp/Co2) and the control (K). K indicates healthy bone in (b). Data are shown as
means with error bars representing standard deviation (* => p < 0.01 with respect to the
control group; ** => p < 0.05 with respect to HAp group, n.s. => non-significant with
respect to the control group).
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Fig. 8.

The histopathology of alveolar bone reconstructed with HApCo2 after 6 (a, b) and 24 weeks
(c, d). The material was mixed with (a, c) blood and (b, d) blood plasma. [labels: 3 replacement of the material with new bone tissue, 4 - a young bone, 5 - cement lines, 6 blood vessel, 8 - Haversian canals, 10 - osteogenesis, 12 - collagen fibers, 13 - mature
calcified bone]
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Fig. 9.

(a) ALP content (U/L) and (b) densities of alveolar bone expressed in Haunsfiled units (HU)
for the control (K) and experimental groups involving the implantation of HAp/Co2 mixed
with saline, blood and blood plasma, 6 and 24 weeks after the implantation. Data are shown
as means with error bars representing standard deviation (* => p < 0.01 with respect to the
control group; ** => p < 0.05 with respect to the control group; n.s. => non-significant with
respect to the control group).
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